AG
Artal Group’s Kura Oncology KURA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-1,819,884
| Closed | -$37.5M | – | 50 |
|
2024
Q2 | $37.5M | Sell |
1,819,884
-100,000
| -5% | -$2.06M | 0.96% | 15 |
|
2024
Q1 | $41M | Buy |
1,919,884
+151,828
| +9% | +$3.24M | 1.04% | 14 |
|
2023
Q4 | $25.4M | Sell |
1,768,056
-250,000
| -12% | -$3.6M | 0.85% | 17 |
|
2023
Q3 | $18.4M | Hold |
2,018,056
| – | – | 0.79% | 19 |
|
2023
Q2 | $21.4M | Buy |
2,018,056
+300,000
| +17% | +$3.17M | 0.66% | 22 |
|
2023
Q1 | $21M | Buy |
1,718,056
+18,056
| +1% | +$221K | 1.25% | 22 |
|
2022
Q4 | $21.1M | Buy |
1,700,000
+600,000
| +55% | +$7.45M | 1.18% | 27 |
|
2022
Q3 | $15M | Buy |
1,100,000
+50,000
| +5% | +$683K | 0.64% | 32 |
|
2022
Q2 | $19.2M | Hold |
1,050,000
| – | – | 1.03% | 22 |
|
2022
Q1 | $16.9M | Hold |
1,050,000
| – | – | 0.71% | 33 |
|
2021
Q4 | $14.7M | Hold |
1,050,000
| – | – | 0.4% | 51 |
|
2021
Q3 | $19.7M | Buy |
1,050,000
+450,000
| +75% | +$8.43M | 0.44% | 48 |
|
2021
Q2 | $12.5M | Hold |
600,000
| – | – | 0.25% | 73 |
|
2021
Q1 | $17M | Hold |
600,000
| – | – | 0.3% | 62 |
|
2020
Q4 | $19.6M | Buy |
600,000
+50,900
| +9% | +$1.66M | 0.42% | 52 |
|
2020
Q3 | $16.8M | Sell |
549,100
-28,900
| -5% | -$885K | 0.41% | 44 |
|
2020
Q2 | $9.42M | Buy |
578,000
+178,000
| +45% | +$2.9M | 0.26% | 60 |
|
2020
Q1 | $3.98M | Hold |
400,000
| – | – | 0.17% | 72 |
|
2019
Q4 | $5.5M | Buy |
400,000
+150,000
| +60% | +$2.06M | 0.21% | 60 |
|
2019
Q3 | $3.79M | Buy |
+250,000
| New | +$3.79M | 0.15% | 68 |
|
2018
Q2 | – | Sell |
-100,000
| Closed | -$1.88M | – | 97 |
|
2018
Q1 | $1.88M | Hold |
100,000
| – | – | 0.02% | 68 |
|
2017
Q4 | $1.53M | Hold |
100,000
| – | – | 0.02% | 68 |
|
2017
Q3 | $1.5M | Buy |
+100,000
| New | +$1.5M | 0.03% | 69 |
|